Gene · 200315
Papers1,983
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,983
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Improved Dual Base Editor Systems (iACBEs) for Simultaneous Conversion of Adenine and Cytosine in the Bacterium Escherichia coli. | mBio | 2023 | 36625577 | PubTator, text mining | PubMed |
| Cellular APOBEC3A deaminase drives mutations in the SARS-CoV-2 genome. | Nucleic Acids Res | 2023 | 36610792 | PubTator, text mining | PubMed |
| American-Asian- and African lineages of Zika virus induce differential pro-inflammatory and Interleukin 27-dependent antiviral responses in human monocytes. | Virus Res | 2023 | 36610657 | PubTator, text mining | PubMed |
| Interleukin-27 Promotes Divergent Effects on HIV-1 Infection in Peripheral Blood Mononuclear Cells through BST-2/Tetherin. | J Virol | 2023 | 36602368 | PubTator, text mining | PubMed |
| HIV-1 Vpr Induces Degradation of Gelsolin, a Myeloid Cell-Specific Host Factor That Reduces Viral Infectivity by Inhibiting the Expression and Packaging of the HIV-1 Env Glycoprotein. | mBio | 2023 | 36602307 | PubTator, text mining | PubMed |
| Hepatocellular carcinoma detection via targeted enzymatic methyl sequencing of plasma cell-free DNA. | Clin Epigenetics | 2023 | 36600275 | PubTator, text mining | PubMed |
| Single-cell DNA methylation sequencing by combinatorial indexing and enzymatic DNA methylation conversion. | Cell Biosci | 2023 | 36600255 | PubTator, text mining | PubMed |
| Mpox diagnostics: Review of current and emerging technologies. | J Med Virol | 2023 | 36571266 | PubTator, text mining | PubMed |
| The Cytidine Deaminase APOBEC3G Contributes to Cancer Mutagenesis and Clonal Evolution in Bladder Cancer. | Cancer Res | 2023 | 36480186 | PubTator, text mining | PubMed |
| Clinical Implications of APOBEC3-Mediated Mutagenesis in Breast Cancer. | Clin Cancer Res | 2023 | 36478188 | PubTator, text mining | PubMed |
| Primary mucosal melanomas of the head and neck are characterised by overexpression of the DNA mutating enzyme APOBEC3B. | Histopathology | 2023 | 36416305 | PubTator, text mining | PubMed |
| Feasibility and Potential of Transcriptomic Analysis Using the NanoString nCounter Technology to Aid the Classification of Rejection in Kidney Transplant Biopsies. | Transplantation | 2023 | 36413151 | PubTator, text mining | PubMed |
| APOBEC3A/B deletion polymorphism and endometrial cancer risk. | Cancer Med | 2023 | 36394079 | PubTator, text mining | PubMed |
| A functional variant of CD40 modulates clearance of hepatitis B virus in hepatocytes via regulation of the ANXA2/CD40/BST2 axis. | Hum Mol Genet | 2023 | 36383401 | PubTator, text mining | PubMed |
| Evolution of an adenine base editor into a small, efficient cytosine base editor with low off-target activity. | Nat Biotechnol | 2023 | 36357719 | PubTator, text mining | PubMed |
| Phenotypic variability in LAMA3-associated amelogenesis imperfecta. | Oral Dis | 2023 | 36326426 | PubTator, text mining | PubMed |
| APOBEC3G protects the genome of human cultured cells and mice from radiation-induced damage. | FEBS J | 2023 | 36325681 | PubTator, text mining | PubMed |
| Fibrostenotic eosinophilic esophagitis phenotype is defined by a proliferative gene signature. | Allergy | 2023 | 36273270 | PubTator, text mining | PubMed |
| RNA Editing Therapeutics: Advances, Challenges and Perspectives on Combating Heart Disease. | Cardiovasc Drugs Ther | 2023 | 36239832 | PubTator, text mining | PubMed |
| Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancer. | Cancer Med | 2023 | 36204983 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/200315/papers?page=19